Literature DB >> 1513869

Effects of piracetam on retention and biogenic amine turnover in albino rats.

K Nalini1, K S Karanth, A Rao, A R Aroor.   

Abstract

The chronic effects of orally administered 2-pyrrolidone acetamide (piracetam) on one-trial, passive avoidance task were studied in albino rats. The effects on the contents of norepinephrine (NE), dopamine (DA), and serotonin (5-HT) in the brain and on the levels of their metabolites both in the brain and urine were also assessed. Significant improvement was observed in the retention ability compared with saline-administered controls. The contents of NE, DA, and 5-HT and their metabolites in the brain were significantly decreased after piracetam administration. The urinary metabolite levels were also significantly decreased except total 3-methoxy-4-hydroxyphenyl glycol (MHPG). These data indicate that piracetam causes an overall decrease in the turnover of central monoamines. Thus, the results of this study implicate the involvement of NE, DA, and 5-HT systems in learning and memory processes. Piracetam did not exert any GABAergic effect as shown by the absence of change in the brain GABA levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513869     DOI: 10.1016/0091-3057(92)90041-d

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  DADS Analogues Ameliorated the Cognitive Impairments of Alzheimer-Like Rat Model Induced by Scopolamine.

Authors:  Apra Manral; Poonam Meena; Vikas Saini; Fouzia Siraj; Shruti Shalini; Manisha Tiwari
Journal:  Neurotox Res       Date:  2016-05-05       Impact factor: 3.911

2.  Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's disease.

Authors:  Zhi-Kun Sun; Hong-Qi Yang; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2013-02-28       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.